Cardio Diagnostics Holdings Inc. reported Q1 2025 revenue of $940.0 (-94.1% YoY), missed analyst consensus of $75.0K by $74.1K. Diluted EPS came in at $-0.97 (-385.0% YoY), beat the $-1.80 consensus by $0.83.
Trailing eight quarters through Q1 2025
Common questions about Cardio Diagnostics Holdings Inc.'s Q1 2025 earnings report.
Cardio Diagnostics Holdings Inc. (CDIO) reported Q1 2025 earnings on May 15, 2025 before market open.
Cardio Diagnostics Holdings Inc. reported revenue of $940.0 and diluted EPS of $-0.97 for Q1 2025.
Revenue missed the consensus estimate of $75.0K by $74.1K. EPS beat the consensus estimate of $-1.80 by $0.83.
Compared to the same quarter a year prior, revenue declined 94.1% from $15.9K a year earlier and diluted EPS declined 385.0% from $-0.20.
You can read the 10-Q periodic report (0001553350-25-000044) directly on SEC EDGAR. The filing index links above go to sec.gov.